Review article · 2026

Engineering immune cells for next-generation therapies

Maosen Han, Jingzhao Lou, Min Pan, Shengkai Xu, Xinyi Jiang, Weiqiang Jing

Journal of Controlled Release, 395, 115012 · Published 12 May 2026 · DOI 10.1016/j.jconrel.2026.115012

View at the publisherCite this paper

In brief

“Engineering immune cells for next-generation therapies” is a 2026 review article by Maosen Han and 5 co-authors, published in Journal of Controlled Release. OpenAlex counts 5 citations as of 18 November 2026, which puts it in the top 3% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
5
Most cited in
2026 (5)
Field-weighted impact
3.73
References
222
Authors
6

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Han, M., Lou, J., Pan, M., Xu, S., Jiang, X., & Jing, W. (2026). Engineering immune cells for next-generation therapies. Journal of Controlled Release, 395, 115012. https://doi.org/10.1016/j.jconrel.2026.115012

MLA 9

Han, Maosen, et al. “Engineering immune cells for next-generation therapies.” Journal of Controlled Release, vol. 395, 2026, p. 115012. https://doi.org/10.1016/j.jconrel.2026.115012.

Chicago

Han, Maosen, Jingzhao Lou, Min Pan, Shengkai Xu, Xinyi Jiang, and Weiqiang Jing. 2026. “Engineering immune cells for next-generation therapies.” Journal of Controlled Release 395: 115012. https://doi.org/10.1016/j.jconrel.2026.115012.

Harvard

Han, M. et al. (2026) ‘Engineering immune cells for next-generation therapies’, Journal of Controlled Release, 395, p. 115012. doi:10.1016/j.jconrel.2026.115012.

IEEE

M. Han, J. Lou, M. Pan, S. Xu, X. Jiang, and W. Jing, “Engineering immune cells for next-generation therapies,” Journal of Controlled Release, vol. 395, p. 115012, 2026, doi: 10.1016/j.jconrel.2026.115012.

BibTeX

@article{han2026engineering,
  title     = {{Engineering immune cells for next-generation therapies}},
  author    = {Han, Maosen and Lou, Jingzhao and Pan, Min and Xu, Shengkai and Jiang, Xinyi and Jing, Weiqiang},
  journal   = {Journal of Controlled Release},
  year      = {2026},
  volume    = {395},
  pages     = {115012},
  doi       = {10.1016/j.jconrel.2026.115012},
  url       = {https://doi.org/10.1016/j.jconrel.2026.115012}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › CAR-T cell therapy research

  • immune cell engineering
  • chimeric antigen receptor T cells
  • genome editing
  • CRISPR
  • mRNA delivery
  • lipid nanoparticles
  • viral vectors
  • in vivo reprogramming

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Han, M., Lou, J., Pan, M., Xu, S., Jiang, X., & Jing, W. (2026). Engineering immune cells for next-generation therapies. Journal of Controlled Release, 395, 115012. https://doi.org/10.1016/j.jconrel.2026.115012

How many times has this paper been cited?

5 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Maosen Han, Jingzhao Lou, Min Pan, Shengkai Xu, Xinyi Jiang, Weiqiang Jing.

What is the DOI of this paper?

10.1016/j.jconrel.2026.115012, permanently at https://doi.org/10.1016/j.jconrel.2026.115012. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.